Aurinia Pharmaceuticals Inc (AUPH)

18.15 -0.22  -1.20% NASDAQ Jan 28, 09:57 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
03/19/2020 16:30 EDT Misc Aurinia Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2019
03/19/2020 Earnings Aurinia Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
11/14/2019 16:30 EST Misc Aurinia Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2019
11/14/2019 Earnings Aurinia Pharmaceuticals Inc Third Quarter Earnings in 2019 Release
08/06/2019 16:30 EDT Misc Aurinia Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
08/06/2019 Earnings Aurinia Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
06/26/2019 Misc Aurinia Pharmaceuticals Inc Annual General Meeting in 2018
05/14/2019 Earnings Aurinia Pharmaceuticals Inc First Quarter Earnings in 2019 Release
05/10/2019 16:30 EDT Misc Aurinia Pharmaceuticals Inc First Quarter Earnings Conference Call in 2019
03/19/2019 16:30 EDT Misc Aurinia Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.auriniapharma.com
  • Investor Relations URL: http://www.auriniapharma.com/dnn/ForInvestors.aspx
  • HQ State/Province: British Columbia
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Mar. 19, 2020
  • Last Earnings Release: Nov. 14, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States followed by China.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.